Functional inhibition of mesenchymal stromal cells (MSC) results in insufficient hematopoietic support in acute myeloid leukemia (AML)

被引:0
|
作者
Geyh, S. [1 ]
Cadeddu, R-P [2 ]
Jaeger, P. [2 ]
Wilk, M. [2 ]
Fenk, R. [2 ]
Germing, U. [2 ]
Kobbe, G. [2 ]
Haas, R. [2 ]
Schroeder, T. [2 ]
机构
[1] Univ Dusseldorf, Fac Med, Dusseldorf, Germany
[2] Univ Klin Dusseldorf, Klin Hamatol Onkol & Klin Immunol, Dusseldorf, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P180
引用
收藏
页码:48 / 48
页数:1
相关论文
共 50 条
  • [11] Characterization of Mesenchymal Stromal Cells (MSCs) Derived From Acute Myeloid Leukemia (AML) Bone Marrow
    Basu, Soumit K.
    Zhao, Xin
    Chien, Sylvia
    Fang, Min
    Oehler, Vivian
    Becker, Pamela S.
    BLOOD, 2011, 118 (21) : 1097 - 1097
  • [12] Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia
    Geyh, Stefanie
    Rodriguez-Paredes, Manuel
    Jaeger, Paul
    Koch, Annemarie
    Bormann, Felix
    Gutekunst, Julian
    Zilkens, Christoph
    Germing, Ulrich
    Kobbe, Guido
    Lyko, Frank
    Haas, Rainer
    Schroeder, Thomas
    HAEMATOLOGICA, 2018, 103 (09) : 1462 - 1471
  • [13] Acute Myelogenous Leukemia (AML) Mesenchymal Stromal Cell (MSC) Have Distinct Protein Expression Patterns Compared to Normal MSC
    Kornblau, Steven M.
    Ruvolo, Peter
    Wang, Rui-Yu
    Ruvolo, Vivian
    Qiu, Yihua
    Battula, Venkata Lokesh
    Zeng, Zhihong
    McQueen, Teresa
    Yoo, Suk-Young
    Konopleva, Marina
    Andreeff, Michael
    BLOOD, 2015, 126 (23)
  • [14] TGFβ1 causes functional inhibition of mesenchymal stromal cells in MDS and AML
    Geyh, S.
    Rodriguez, M.
    Jaeger, P.
    Koch, A.
    Bormann, F.
    Gutekunst, J.
    Zilkens, C.
    Germing, U.
    Kobbe, G.
    Haas, R.
    Schroeder, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 18 - 18
  • [15] Functional impairment and decreased osteogeneic differentiation capacity of Mesenchymal Stromal Cells (MSC) from patients with Myelodysplastic Syndromes (MDS) result in insufficient stromal support for CD34 Hematopoietic Stem and Progenitor Cells (HSPC)
    Schroeder, T. M.
    Geyh, S.
    R-P, Cadeddu
    Froebel, J.
    Arends, S.
    Huenerlituerkoglu, A-N
    Kuendgen, A.
    Hermsen, D.
    Fenk, R.
    Kobbe, G.
    Germing, U.
    Haas, R.
    ONKOLOGIE, 2012, 35 : 16 - 17
  • [16] Inhibition of Telomerase with Imetelstat Is Detrimental to Leukemia Stem Cells in Acute Myeloid Leukemia (AML)
    Bruedigam, Claudia
    Bagger, Frederik Otzen
    Heidel, Florian H.
    Kuhn, Catherine
    Guignes, Solene
    Song, Axia
    Austin, Rebecca
    Vu, Therese
    Lee, Erwin M.
    Moore, Andrew S.
    Lock, Richard B.
    Bullinger, Lars
    Hill, Geoff R.
    Lane, Steven W.
    BLOOD, 2014, 124 (21)
  • [17] Remodelling of Mesenchymal Stromal Niche by Acute Myeloid Leukemia
    Bonnet, Dominique
    ANNALS OF HEMATOLOGY, 2017, 96 : S17 - S18
  • [18] Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors
    Chandran, Priya
    Le, Yevgeniya
    Li, Yuhua
    Sabloff, Mitchell
    Mehic, Jelica
    Rosu-Myles, Michael
    Allan, David S.
    LEUKEMIA RESEARCH, 2015, 39 (04) : 486 - 493
  • [19] Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia
    Borella, Giulia
    Da Ros, Ambra
    Borile, Giulia
    Porcu, Elena
    Tregnago, Claudia
    Benetton, Maddalena
    Marchetti, Anna
    Bisio, Valeria
    Montini, Barbara
    Michielotto, Barbara
    Cani, Alice
    Leszl, Anna
    Campodoni, Elisabetta
    Sandri, Monica
    Montesi, Monica
    Bresolin, Silvia
    Cairo, Stefano
    Buldini, Barbara
    Locatelli, Franco
    Pigazzi, Martina
    BLOOD, 2021, 138 (07) : 557 - 570
  • [20] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ADULTS WITH ACUTE MYELOID LEUKEMIA (AML): THE TUNISIAN RESULTS
    Torjemane, L.
    Abdejlil, N.
    Lakhal, A.
    Barhoumi, W.
    Ben Hamed, L.
    Kaabi, H.
    Slama, H.
    Laamouri, A.
    Ladeb, S.
    Ben Othman, T.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S112 - S112